Answers are grounded in this paper and cite their sources.
, Tau-squared, and Tau. The birth prevalence meta-analysis yielded a pooled estimate of 31.5 (95% CI: 18.2-54.7) per 100,000 female live births. Studies from Europe (compared to Asia) and those with a lifetime case ascertainment period (compared to first year) reported significantly higher birth prevalence. Meta-regression analysis indicated that studies with lifetime case ascertainment had 2.69 times higher prevalence. Case ascertainment period, diagnostic method, and geography accounted for ~90% of the variation in the birth prevalence estimates across studies. The pooled estimate of point/period prevalence was 23.1 (95% CI: 11.4-46.8) per 100,000 females.
No takes yet. Share an insight, caveat, or question.
Hinds et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: